Delivery Order SPE2DB20D2014-SPE2DB25FC70U
- Not listed
- The Defense Logistics Agency (DLA) awarded a $61,593.00 delivery order to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial A-C-Y-W-135-DIP (0.5ML), a meningococcal vaccine product. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 1, 2025, and was competitively awarded without any set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,144.90 to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by August 18, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,659.15 to AmerisourceBergen Drug Corp for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5 mL, a meningococcal vaccine. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by August 12, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $13,397.27 on August 12, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine. This firm fixed price delivery order, with an ultimate completion date of August 13, 2025, carries no set-aside designation and represents a competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $79,278.21 delivery order to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This firm fixed-price contract, awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a non-competitive set-aside delivery order issued under AmerisourceBergen's broader indefinite delivery contract with DLA Troop Support Medical. The place of performance is the company's corporate...
- The Defense Logistics Agency awarded a $152,714.53 delivery order to AmerisourceBergen Drug Corp for Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML vaccine products, with an ultimate completion date of July 28, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX...
- The Defense Logistics Agency awarded a delivery order valued at $12,318.60 to AmerisourceBergen Drug Corp for the supply of Menveo 1 vial combination vaccine (A-C-Y-W-135-DIP) in 0.5mL dosage. This non-competitive delivery order, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a time-sensitive pharmaceutical procurement fulfilled from the vendor's location in Conshohocken, Pennsylvania. The order falls under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a $18,746.76 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Menveo (1 vial A-C-Y-W-135-DIP 0.5mL), a meningococcal conjugate vaccine. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery location is the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $92,818.40 to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This competitively awarded, firm fixed-price delivery order was issued on July 25, 2025, with an ultimate completion date of July 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation,...
- The Defense Logistics Agency awarded a $2,014.32 delivery order to AmerisourceBergen Drug Corp for Menveo A-C-Y-W Kit (2 vials), a meningococcal vaccine product. This firm fixed-price delivery order was competitively awarded without set-aside designation and is due for completion by August 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order, this delivery is executed under AmerisourceBergen's larger Indefinite...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC70UDelivery Order
The Defense Logistics Agency (DLA) awarded a $11,671.29 delivery order to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial A-C-Y-W-135-DIP 0.5mL, a meningococcal conjugate vaccine. This competitively awarded, firm fixed-price contract contains no set-aside designation and is scheduled for completion by August 12, 2025. Performance will occur at the contractor's location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's substantial $999.999 billion Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which runs through December 2026 and serves as the global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has established itself as a critical federal medical procurement vendor, particularly for the Department of Defense and military healthcare systems. As a prime contractor under the DLA Troop Support Medical IDC, the company supplies a comprehensive range of pharmaceutical products and medical supplies, including vaccines, medications, and specialty medical commodities across multiple therapeutic domains. This delivery order for meningococcal vaccine procurement exemplifies the company's ongoing role in supporting military readiness and force health protection through the DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.7k | 8/11/25 |